Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome

被引：75

作者：

Devaraj, Sridevi ^{[1
,2
]}

Valleggi, Simona ^{[1
,2
]}

Siegel, David ^{[2
]}

Jialal, Ishwarlal ^{[1
,2
]}

机构：

[1] Univ Calif Davis, Med Ctr, Lab Atherosclerosis & Metab Res, Sacramento, CA 95817 USA

[2] Vet Affairs Med Ctr, Mather, CA USA

来源：

CURRENT ATHEROSCLEROSIS REPORTS | 2010年 / 12卷 / 02期

关键词：

CRP; Metabolic syndrome; Inflammation; Cardiovascular risk; CORONARY-HEART-DISEASE; ACTIVATOR INHIBITOR-1 EXPRESSION; INSULIN-RESISTANCE SYNDROME; AORTIC ENDOTHELIAL-CELLS; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; BRACHIAL-ARTERY; KINASE PATHWAY; OXIDIZED LDL;

D O I：

10.1007/s11883-010-0098-3

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Metabolic syndrome is associated with increased propensity for diabetes and cardiovascular disease. Low-grade inflammation is characteristic of metabolic syndrome. C-reactive protein, the best characterized biomarker of inflammation, is also an independent predictor of future cardiovascular events. This review outlines the role of high-sensitivity C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome by inducing endothelial cell dysfunction and activating monocytes.

引用

页码：110 / 118

页数：9

共 90 条

[41] C-reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes
Han, KH
Hong, KH
Park, JH
Ko, JS
Kang, DH
Choi, KJ
Hong, MK
Park, SW
Park, SJ
[J]. CIRCULATION, 2004, 109 (21) : 2566 - 2571
[42] Components of the "metabolic syndrome" and incidence of type 2 diabetes
Hanson, RL
Imperatore, G
Bennett, PH
Knowler, WC
[J]. DIABETES, 2002, 51 (10) : 3120 - 3127
[43] The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort
Holvoet, P
Kritchevsky, SB
Tracy, RP
Mertens, A
Rubin, SM
Butler, J
Goodpaster, B
Harris, TB
[J]. DIABETES, 2004, 53 (04) : 1068 - 1073
[44] Role of endothelial dysfunction in insulin resistance
Hsueh, WA
Quiñones, MJ
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (4A) : 10J - 17J
[45] Inflammatory markers in relation to insulin resistance and the metabolic syndrome
Ingelsson, E.
Hulthe, J.
Lind, L.
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (07) : 502 - 509
[46] Statin Therapy for the Metabolic Syndrome: The Evidence Base
Jialal, Ishwarlal
Devaraj, Sridevi
[J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (05) : 393 - 395
[47] Obesity and systemic oxidative stress - Clinical correlates of oxidative stress in the Framingham Study
Keaney, JF
Larson, MG
Vasan, RS
Wilson, PWF
Lipinska, I
Corey, D
Massaro, JM
Sutherland, P
Vita, JA
Benjamin, EJ
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (03) : 434 - 439
[48] Interaction of oxidative stress and inflammatory response in coronary plaque instability - Important role of C-reactive protein
Kobayashi, S
Inoue, N
Ohashi, Y
Terashima, M
Matsui, K
Mori, T
Fujita, H
Awano, K
Kobayashi, K
Azumi, H
Ejiri, J
Hirata, K
Kawashima, S
Hayashi, Y
Yokozaki, H
Itoh, H
Yokoyama, M
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) : 1398 - 1404
[49] Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: Results from the MONICA/KORA Augsburg cohort study, 1984-1998
Koenig, Wolfgang
Khuseyinova, Natalie
Baumert, Jens
Meisinger, Christa
[J]. CLINICAL CHEMISTRY, 2008, 54 (02) : 335 - 342
[50] Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk
Kressel, Gaby
Trunz, Birgit
Bub, Achim
Huelsmann, Olaf
Wolters, Maike
Lichtinghagen, Ralf
Stichtenoth, Dirk O.
Hahn, Andreas
[J]. ATHEROSCLEROSIS, 2009, 202 (01) : 263 - 271

← 1 2 3 4 5 6 7 8 9 →